Luminelle inks marketing agreement with USWHA for endoscopic system

Luminelle, an innovative medical device company, announces a substantial marketing agreement with the U.S. Women’s Health Alliance (USWHA), an organization focused on promoting high-quality, affordable healthcare for women.

Under the agreement, the LUMINELLE® SUSTAINE Endoscopic system will be made available to OBGYN medical practices and their patients across USWHA’s 1100+ Alliance health care practices nationwide, enabling USWHA Members to provide their patients an alternative to costly hospital procedures with the new FDA-cleared Luminelle SUSTAINE Endoscopy system. In turn, the agreement will give Luminelle access to over 5000 providers in 34 states. The Luminelle SUSTAINE system is used to diagnose and treat numerous uterine and urological conditions easily and affordably and answer a call to fill an unmet medical need.

“We are delighted to partner with the USWHA and its members,” said Luminelle CEO Allison London Brown. “We have a shared mission in providing better clinical outcomes and cost-effective solutions to gynecological practices and their patients, which is increasingly important, especially in these economically challenging times. We are committed to delivering the USWHA members a lower-cost alternative for physicians to treat patients in their office, and to provide practices the best option for care.”

“The U.S. Women’s Health Alliance is committed to improving the quality and affordability of women’s care,” says Jack Feltz, MD, President of USWHA. “We champion physicians and patients by bringing the best and latest technology to the office setting. We believe that devices like Luminelle are essential to delivering simple and cost-effective diagnosis and treatment options for women. Through this partnership with Luminelle, the mission of the U.S. Women’s Health Alliance to ‘help private practices thrive in a new healthcare environment’ will be advanced.” Business Wire